INVESTOR ALERT: Kirby McInerney LLP Commences Investigation on Behalf of Trinity Biotech plc Investors
August 10 2017 - 6:37PM
Business Wire
The law firm of Kirby McInerney LLP announced today an
investigation on behalf of investors of Trinity Biotech plc
(“Trinity” or the “Company”) (NASDAQ:TRIB) concerning possible
violations of federal securities laws by the Company and/or certain
of its officers and directors.
Trinity acquires, develops, manufactures and markets medical
diagnostic products for the clinical laboratory and point-of-care
(POC) segments of the diagnostic market.
The investigation concerns Trinity’s October 4, 2016
announcement that the Company was withdrawing its 510(k) premarket
notification submission for the Meritas Troponin-I Test and Meritas
Point-of-Care Analyzer on the recommendation of the U.S. Food and
Drug Administration. On news of the withdrawal, Trinity’s share
price fell over 50% to close at just $6.46 per share on October 4,
2016, thereby injuring investors.
If you purchased or otherwise acquired shares of Trinity and
would like more information pertaining to the investigation, please
contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600 or
by email at telrod@kmllp.com to discuss your rights or interests
with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm
concentrating in securities, antitrust, whistleblower and consumer
litigation. The firm’s efforts on behalf of shareholders in
securities litigation have resulted in recoveries totaling billions
of dollars, and the firm's achievements and quality of service have
been chronicled in numerous published decisions. Additional
information about the firm can be found at Kirby McInerney LLP’s
website: http://www.kmllp.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170810006262/en/
Kirby McInerney LLPThomas W. Elrod,
212-371-6600telrod@kmllp.comhttps://www.kmllp.com
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Sep 2023 to Sep 2024